OpenBilldrug price receipt

NADAC week of 2026-10-14

LODOCO 0.5 MG TABLET

FDA nonproprietary name: colchicine tablets 0.5 mg

For 30 tablets

Pharmacies pay

$509.98 filed

30 × $16.99949 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-29 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$472.10 filed

30 × $15.73676 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.93× estimated

Medicare paid 7% less than pharmacies pay.

Part D averages every strength and form sold under “Lodoco” / “Colchicine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2025-12-29 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$591.48 estimated

$509.98 + $76.50 (15%) + $5.00 fee per fill = $591.48

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2025-12-29 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LODOCO 0.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as colchicine tablets 0.5 mg, under the trade name “LODOCO”.

FDA gives its dosage form as tablet and its route as oral.

The labeler, the company named on the label, is AGEPHA Pharma USA, LLC.

FDA’s Established Pharmacologic Class for it is Alkaloid.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 82867-0001-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $509.98 for 30 tablets (30 × $16.99949 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2025-12-29. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2025-12-29. The file is new; the price is not.

The NDC

Compared with its class

Its NADAC price is $16.99949 per EA filed.

Of the 4 other products in FDA’s Alkaloid class priced per EA, 0 have a higher middle NADAC price and 4 a lower one. The one in the middle is PROBENECID-COLCHICINE TABLET, at $0.83043 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-29, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $472.10 for 30 tablets, at an average of $15.73676 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lodoco” and “Colchicine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 723 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for LODOCO 0.5 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Lodoco / Colchicine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.